Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001554795-22-000107
Filing Date
2022-03-22
Accepted
2022-03-22 13:58:53
Documents
40
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K cncl0322form10k.htm   iXBRL 10-K 327336
2 EXHIBIT 31.1 cncl0322form10kexh31_1.htm EX-31.1 8030
3 EXHIBIT 31.2 cncl0322form10kexh31_2.htm EX-31.2 8007
4 EXHIBIT 32.1 cncl0322form10kexh32_1.htm EX-32.1 3781
  Complete submission text file 0001554795-22-000107.txt   1536359

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE cncl-20211231.xsd EX-101.SCH 12755
6 XBRL CALCULATION FILE cncl-20211231_cal.xml EX-101.CAL 22218
7 XBRL DEFINITION FILE cncl-20211231_def.xml EX-101.DEF 14504
8 XBRL LABEL FILE cncl-20211231_lab.xml EX-101.LAB 118827
9 XBRL PRESENTATION FILE cncl-20211231_pre.xml EX-101.PRE 90424
34 EXTRACTED XBRL INSTANCE DOCUMENT cncl0322form10k_htm.xml XML 98310
Mailing Address 2157 S. LINCOLN SUITE 200 SALT LAKE CITY UT 84106
Business Address 2157 S. LINCOLN SUITE 200 SALT LAKE CITY UT 84106 801-323-2395
CANCER CAPITAL CORP (Filer) CIK: 0001130889 (see all company filings)

EIN.: 911803648 | State of Incorp.: WY | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-32363 | Film No.: 22758680
SIC: 6770 Blank Checks